Healthcare
Nordic PE healthcare deals in need of resuscitation
Dwindling healthcare dealflow belies the Nordic region's strong fundamentals
Inveready backs Galgo in €1m round
VC used €15m second biotech fund
SEB Venture Capital leads SEK 93m round for OssDsign
Existing investor Karolinska participated alongside Fouriertransform
CureVac raises €100m from Baillie Gifford et al.
Funding round is among the largest capital increases in German biotech
Gimv injects €12.5m into Zorgbedrijven
GP to secure minority stake in clinic operator
Wellington-backed Neuway extends series-A to €5.85m
Company is first spinout from Life Science Inkubator
Mologic raises £3m from Calculus Capital
Diagnostic devices developer was founded in 2003
Life Sciences Partners’ Curetis sets IPO price range
Company hopes to raise up to €50m
Sequana Medical raises CHF 9m series-C extension
New investors Salus Partners and Quest for Growth provide CHF 3.7m
Equistone’s Concept Life Sciences bolts on Agenda1
Acquisition part of buy-and-build strategy
Amundi et al. back Numerix bolt-on of GIOL
New investors back bolt-on with capital increase
Charterhouse buys Cooper in first deal for latest fund
French pharma is understood to be worth in the region of €700m
Curetis eyes IPO on Euronext
Company was founded in 2007
Luxendo closes €6m series-A
Company is spin-off from European Molecular Biology Laboratory
Ysios et al. inject €19.4m into Minoryx
Other backers include Kurma, Idinvest and Chiesi
Redalpine scores 10x exit from InSphero
Asset sold to family office
Palatine purchases Vernacare
GP takes majority stake in healthcare equipment business
Pathena backs TNI’s second round with €3m
GP has €50m under management
Monitor’s STS bolts on MSS
Acquisition of sixth unit follows Luigi Salvadori add-on in May
Catapult makes 5.2x on Oxford Cryosystems exit
Company's management buys back Catapult's stake
SFPI-FPIM et al. in €16m series-B for Euroscreen
Drug developer has received €28m in funding since 2012
CapMan exits Swereco in SEK 250m deal
Equity price is SEK 250m, CapMan sells 37.5% stake
OrbiMed et al. in $35m series-A for Therachon
Injection follows seed round for business in 2014
MML acquires Energy Medical Services
GP plans on following buy-and-build strategy